INS and diabetes mellitus: While our data demonstrate impaired insulin sensitivity, low-dose GC treatment is associated with a lower incidence of diabetes in prospective studies [47], possibly due to reliance on fasting glucose measurements, which does not capture nuanced changes in glucose handlining and insulin sensitivity.